SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-016259
Filing Date
2023-10-05
Accepted
2023-10-05 16:15:27
Documents
15
Period of Report
2023-09-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hrmy-20230930x8k.htm   iXBRL 8-K 46865
2 EX-10.1 hrmy-20230930xex10d1.htm EX-10.1 46294
3 EX-10.2 hrmy-20230930xex10d2.htm EX-10.2 41317
4 GRAPHIC hrmy-20230930x8k001.jpg GRAPHIC 1167
  Complete submission text file 0001558370-23-016259.txt   277093

Data Files

Seq Description Document Type Size
5 EX-101.SCH hrmy-20230930.xsd EX-101.SCH 3163
6 EX-101.LAB hrmy-20230930_lab.xml EX-101.LAB 15928
7 EX-101.PRE hrmy-20230930_pre.xml EX-101.PRE 10081
9 EXTRACTED XBRL INSTANCE DOCUMENT hrmy-20230930x8k_htm.xml XML 4879
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

IRS No.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39450 | Film No.: 231311518
SIC: 2834 Pharmaceutical Preparations